Highest development stage: Preclinical

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: At least 4 fold more active against a Klebsiella infection than clarithromycin and erythromycin

Additional information: Gill CJ, Abruzzo GK, Flattery A, et al. In vivo evaluation of three acid-stable azalide compounds, L-701677, L-708299 and L-708365 in comparison with erythromycin, azithromycin, and clarithromycin. 33rd-Intersci-Conf-Antimicrobial-Agents-Chemother 1993; 197.